Inventor · disambiguated record
Tomas Hanke
Also filed as: HANKE TOMAS
10 granted patents·8 pending applications·79 citations·filing 1999–2024
87Inventor score
Files withOXXON THERAPEUTICS LTD5HANKE TOMAS3LOS ALAMOS NAT SECURITY LLC2MEDICAL RES COUNCIL2OXXON PHARMACCINES LTD2
Top patents by PatentIndex Score
18 records- 0190US7981430B2Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteomeMEDICAL RES COUNCIL·Filed 2007·Granted Jul 19, 2011·11 cites·2 claims
- 0284US7993651B2Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopesMEDICAL RES COUNCIL·Filed 2000·Granted Aug 9, 2011·11 cites·15 claims
- 0382US6663871B1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON PHARMACCINES LTD·Filed 1999·Granted Dec 16, 2003·47 cites·20 claims
- 0480US10010606B2Mosaic conserved region HIV immunogenic polypeptidesLOS ALAMOS NAT SECURITY LLC·Filed 2014·Granted Jul 3, 2018·2 cites·20 claims
- 0579US12364750B1Conserved region T cell vaccines for coronavirus and methods of useTRIAD NAT SECURITY LLC·Filed 2024·Granted Jul 22, 2025·0 cites·20 claims
- 0675US7514087B2Methods and reagents for immunization which generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2004·Granted Apr 7, 2009·4 cites·29 claims
- 0775US7407661B2Methods and reagents that generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2004·Granted Aug 5, 2008·4 cites·25 claims
- 0874US2009324632A1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 0972US2009191237A1Methods and reagents for vaccination which generate A CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 1069US12023376B1Conserved region T cell vaccines for coronavirus and methods of useTRIAD NAT SECURITY LLC·Filed 2021·Granted Jul 2, 2024·0 cites·15 claims
- 1167US11235055B2Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptidesLOS ALAMOS NAT SECURITY LLC·Filed 2018·Granted Feb 1, 2022·0 cites·19 claims
- 1266US2010119551A1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 1361US2004131594A1Methods and reagents for vaccination which generate a CD8 T cell immune responseFiled 2003·Application pending·0 cites
- 1460US2011159034A1Methods and reagents for vaccination which generate a cd8 t cell immune responseMCMICHAEL ANDREW·Filed 2010·Application pending·0 cites
- 1553US2004213799A1Methods and reagents for vaccination which generate a CD8 T cell immune responseOXXON PHARMACCINES LTD·Filed 2003·Application pending·0 cites
- 1642US8728485B2Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteomeHANKE TOMAS·Filed 2010·Granted May 20, 2014·0 cites·8 claims
- 1738US2008306244A1Renta: an HIV immunogen and uses thereofHANKE TOMAS·Filed 2006·Application pending·0 cites
- 1831US2011177115A1Vaccination regimenHANKE TOMAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tomas Hanke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →